These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1920906)

  • 1. [Two patients of CREST-primary biliary cirrhosis overlap syndrome with common HLA types].
    Kojima T; Ohira Y; Ishibashi K; Kuroda M; Takagi T; Saito K; Nishimaki T; Kasukawa R; Morito T; Oonami K
    Nihon Shokakibyo Gakkai Zasshi; 1991 Jul; 88(7):1479-84. PubMed ID: 1920906
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: HL-A antigens in progressive systemic sclerosis (scleroderma).
    Rabin BS; Rodnan GP; Bassion S; Gill TJ
    Arthritis Rheum; 1975; 18(4):381-2. PubMed ID: 1156459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
    Rouquette-Gally AM; Stern MH; Prost AC; Abuaf N; Homberg JC; Combrisson A
    Presse Med; 1985 Jul 13-20; 14(28):1497-500. PubMed ID: 2931679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-centromere antibodies (ACA).
    Kallenberg CG
    Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):136-9. PubMed ID: 2203592
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticentromere antibody, CREST and cancer].
    Boyeldieu D; Rouquette-Gally AM; Laugier A; Abuaf N
    Presse Med; 1987 Nov; 16(38):1924-5. PubMed ID: 2962150
    [No Abstract]   [Full Text] [Related]  

  • 6. Coexistence of CREST syndrome and primary biliary cirrhosis. Serological studies of two cases.
    Hirakata M; Akizuki M; Miyachi K; Matsushima H; Okano T; Homma M
    J Rheumatol; 1988 Jul; 15(7):1166-70. PubMed ID: 3172118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of the anticentromere antibody.
    Miller MH; Littlejohn GO; Davidson A; Jones B; Topliss DJ
    Br J Rheumatol; 1987 Feb; 26(1):17-21. PubMed ID: 3493051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodular regenerative hyperplasia of the liver, CREST syndrome and primary biliary cirrhosis: an overlap syndrome?
    McMahon RF; Babbs C; Warnes TW
    Gut; 1989 Oct; 30(10):1430-3. PubMed ID: 2583572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases.
    Powell FC; Schroeter AL; Dickson ER
    Q J Med; 1987 Jan; 62(237):75-82. PubMed ID: 3423208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis.
    Shoji I; Takagi T; Kasukawa R
    Intern Med; 1992 Dec; 31(12):1348-55. PubMed ID: 1284406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histocompatibility antigens in progressive systemic sclerosis (scleroderma).
    Birnbaum NS; Rodnan GP; Rabin BS; Bassion S
    J Rheumatol; 1977; 4(4):425-8. PubMed ID: 604479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
    Fritzler MJ; Kinsella TD
    Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anticentromere antibody: disease specificity and clinical significance.
    Powell FC; Winkelmann RK; Venencie-Lemarchand F; Spurbeck JL; Schroeter AL
    Mayo Clin Proc; 1984 Oct; 59(10):700-6. PubMed ID: 6384675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
    Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M
    Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnosis of Osler's telangiectasia and the CREST syndrome: significance of centromere antibodies].
    Stolz W; Ring J; Meurer M
    Hautarzt; 1988 Jun; 39(6):371-4. PubMed ID: 3403273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reynolds' syndrome: the combination of scleroderma of CREST syndrome type and primary biliary cirrhosis].
    Leclech C; Friedel J; Jeandel C; Lux C; Heid E
    Ann Dermatol Venereol; 1987; 114(6-7):857-9. PubMed ID: 3674670
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterisation of centromere (kinetochore) antigen reactive with sera of patients with a scleroderma variant (CREST syndrome).
    Nishikai M; Okano Y; Yamashita H; Watanabe M
    Ann Rheum Dis; 1984 Dec; 43(6):819-24. PubMed ID: 6524984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants.
    McCarty GA; Rice JR; Bembe ML; Barada FA
    Arthritis Rheum; 1983 Jan; 26(1):1-7. PubMed ID: 6337593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome.
    Reynolds TB; Denison EK; Frankl HD; Lieberman FL; Peters RL
    Am J Med; 1971 Mar; 50(3):302-12. PubMed ID: 5553949
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased prevalence of DRw3 in the CREST syndrome.
    Germain BF; Espinoza LR; Bergen LL; Vagesh M; Vasey FB
    Arthritis Rheum; 1981 Jun; 24(6):857-9. PubMed ID: 6941787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.